Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Dicycloverine 10mg tablets
0102000J0AAABAB
|
Dicycloverine hydrochloride | Dicycloverine hydrochloride | Gastro-Intestinal System | 4,337 |
|
Dicycloverine 20mg tablets
0102000J0AAACAC
|
Dicycloverine hydrochloride | Dicycloverine hydrochloride | Gastro-Intestinal System | 3,098 |
|
Dicycloverine 10mg/5ml oral solution
0102000J0AAAAAA
|
Dicycloverine hydrochloride | Dicycloverine hydrochloride | Gastro-Intestinal System | 493 |
|
Dicycloverine 10mg/5ml oral solution sugar free
0102000J0AAADAD
|
Dicycloverine hydrochloride | Dicycloverine hydrochloride | Gastro-Intestinal System | 16 |
|
Merbentyl 10mg tablets
0102000J0BBAAAB
|
Merbentyl | Dicycloverine hydrochloride | Gastro-Intestinal System | No data available |
|
Merbentyl 10mg/5ml syrup
0102000J0BBABAA
|
Merbentyl | Dicycloverine hydrochloride | Gastro-Intestinal System | No data available |
|
Merbentyl 20 tablets
0102000J0BBAEAC
|
Merbentyl | Dicycloverine hydrochloride | Gastro-Intestinal System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.